Treatment of megaloblastic anemias

Megaloblastic anemia is almost always the consequence of a deficiency state. The proper management of this disorder requires the identification of the nature of the underlying abnormality, since this dictates the choice of the specific therapeutic agent for the deficiency, the duration of treatment...

Full description

Saved in:
Bibliographic Details
Published inJournal of chronic diseases Vol. 6; no. 4; pp. 287 - 301
Main Authors McIntyre, Patricia A., Krevans, Julius R., Conley, C.Lockard
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.10.1957
Subjects
Anemia - therapy
Anemia, Megaloblastic
Humans
Old Medline
Tracheophyta
ANEMIA, HYPERCHROMIC/therapy
Online AccessGet full text

Cover

More Information
Summary:Megaloblastic anemia is almost always the consequence of a deficiency state. The proper management of this disorder requires the identification of the nature of the underlying abnormality, since this dictates the choice of the specific therapeutic agent for the deficiency, the duration of treatment required, and the other therapeutic measures which may be necessary.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0021-9681
DOI:10.1016/0021-9681(57)90024-3